J&J is reporting a “temporary” scarcity of Tylenol after heightened demand for the over-the-counter drug has strained supply, the drugmaker said in a statement.
The shortage is limited to specific regions, and J&J says it’s speeding up production to meet the increase demand. J&J is working with retailers to “encourage” purchasing limits and is working to keep supplies running to consumers and hospitals.
“We are committed to maintaining our increased production, including running lines up to 24/7 to maximize supply,” J&J said in a statement.
The spot shortages of Tylenol come as U.S. consumers have focused in on the global pharmaceutical supply chain’s ability to keep up with increased demand amid the novel coronavirus pandemic...
Full text GMPnews.Net